MET and breast cancer: Previous studies have shown that CCR2 regulated MET expression and MET expression is important for HGF signaling and CCL2/CCR2 signaling in breast cancer cells.27 Therefore, how would targeting CCR2 and MET affect CCL2 and HGF signaling in these studies?